The zero-price warrant exercise feature creates a massive overhang of up to 72 million potential shares, which will likely pressure the stock price. Monitor for immediate warrant exercises and subsequent selling. The 45-day suspension of the ATM program provides temporary relief, but the dilutive structure suggests continued equity dependence.
Price Chart
Executive Summary
China SXT Pharmaceuticals (SXTC) filed a 6-K disclosing a securities purchase agreement for a registered direct offering of up to 8,000,000 units (plus an over-allotment option for up to 8,000,000 additional units) at $1.50 per unit, each consisting of one Class A ordinary share (or pre-funded warrant) and one warrant to purchase one Class A ordinary share. The offering targets up to $9,000,000 in gross proceeds (up to $12,000,000 with the over-allotment option), with warrants exercisable at $2.75 per share for one year and featuring a zero-price exercise mechanism that could result in the issuance of up to 72,000,000 additional shares without cash proceeds. This capital raise, filed alongside a 424B5 prospectus supplement, is highly dilutive to existing shareholders and signals ongoing cash needs.
Key Facts
- Offering of up to 8,000,000 units (plus 8,000,000 over-allotment) at $1.50 per unit, each unit consisting of one Class A ordinary share (or pre-funded warrant) and one warrant.
- Gross proceeds target of up to $9,000,000 (up to $12,000,000 with over-allotment).
- Warrants have a one-year term, exercise price of $2.75, and include a zero-price exercise feature that could issue up to 72,000,000 additional shares without cash proceeds.
- The company expects no cash proceeds from warrant exercises due to the zero-price exercise mechanism.
- Placement agent Univest Securities receives a 7% cash fee and up to $50,000 in expense reimbursement.
- The offering includes a 30-day over-allotment option for up to $12,000,000 in additional securities.
- The company has suspended its ATM program and pre-paid advance facility for 45 days post-closing.
Financial Impact
Up to $12,000,000 in gross proceeds from the offering, but with massive potential dilution: up to 8,000,000 shares from the units plus up to 72,000,000 additional shares from warrant exercises (zero-price), totaling up to 80,000,000 potential new shares. Current market cap is not provided, but the dilution is severe relative to the company's likely small market cap.
Risk Factors
- Extreme dilution from warrant exercises (up to 72M shares at zero price) could crush the stock price.
- The company may need further capital raises, indicating ongoing financial distress.
- Low stock price could trigger delisting risk from Nasdaq if it falls below $1.00.
- The offering structure (units with warrants) is typical of distressed micro-cap companies.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-108557 |
| Document: ea030821701ex4-1.htm | 0001213900-26-108557 |
| Document: ea030821701ex10-2.htm | 0001213900-26-108557 |
| Document: ea030821701ex4-2.htm | 0001213900-26-108557 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 4d ago | 6-K | $0.0480 | awaiting T+5 | — | — |
Oct 15, 2026 10d ago | SC 13G | $0.0650 $0.0410 | ▼ −36.92% | ▼ −36.49% | — |
Oct 9, 2026 16d ago | 6-K | $0.1020 $0.1112 | ▼ −9.02% | ▼ −10.51% | — |
Oct 9, 2026 17d ago | 424B5 | $0.1487 $0.0650 | ▲ +56.29% | ▲ +54.32% | — |
Oct 8, 2026 18d ago | 6-K | $0.3435 $0.0688 | ▲ +79.97% | ▲ +79.69% | — |
Oct 8, 2026 18d ago | 6-K | $0.3435 $0.0688 | ▲ +79.97% | ▲ +79.69% | — |
Sep 17, 2026 5w ago | EFFECT | $2.44 $2.55 | ▼ −4.72% | ▼ −4.12% | — |
Aug 28, 2026 8w ago | 6-K | $2.56 $2.24 | ▲ +12.50% | ▲ +12.36% | — |
Jul 24, 2026 13w ago | 424B5 | $0.0638 $0.0618 | ▲ +3.13% | ▲ +4.23% | — |
Jun 1, 2026 20w ago | 424B5 | $1.78 $1.56 | ▲ +12.36% | ▲ +9.39% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers